Skip to main content

Table 1 Clinical and laboratory characteristics of 60 adults with acute myeloid leukemia

From: Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients

ParameterValue (mean ± SD) or distribution (n (%))
Age (years)36.8 ± 1.6
Gender
 Male27 (45.0)
 Female33 (55.0)
Hepatomegaly25 (41.6)
Splenomegaly23 (38.3)
Lymphadenopathy12 (20.0)
Total leukocytic count (× 109/L)49.8 ± 7.6
Hemoglobin (g/dL)8.1 ± 0.2
Platelets (× 109/L)56.7 ± 9.8
Peripheral-blood blasts (%)50.4 ± 26.4
Bone-marrow blasts (%)62.3 ± 20.7
Bone-marrow cellularitya
 Normocellular9 (15.0)
 Hypercellular51 (85.0)
Cytogenetics and molecular classification
 Normal karyotype9 (15.0)
t(5:17)6 (10.0)
t(8;21)6 (10.0)
t(9;12)5 (8.3)
 Trisomy 212 (3.3)
 Inversion 161 (1.7)
 Trisomy 31 (1.7)
Multiple9 (15.0)
Cytogenetics not performed21 (35.0)
FLT3 status
 Wild type51 (85.0)
 Mutant9 (15.0)
French–American–British classification
 M17 (11.7)
 M220 (33.3)
 M35 (8.3)
 M414 (23.3)
 M5a4 (6.7)
 M71 (1.7)
CD34 status
 Positive35 (58.3)
 Negative25 (41.6)
  1. aCellularity is the volume ratio of hematopoiesis and fat. Normal of an adult 30 to 70% and hypercellular over 70%